Biogen (BIIB) PT Raised to $290 at Baird

October 28, 2026 5:01 PM EDT Send to a Friend
Baird analyst Brian Skorney raised the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $250.00) while maintaining a Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login